Another target of A-to-I editing is miR-381, a microRNA involved in stemness and chemoresistance [132,133] that is overedited in non-small cell lung carcinoma (NSCLC) cell lines harboring the genomic amplification of ADAR1. The gene discussed is ADAR; the disease is non-small cell lung carcinoma.